BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2851393)

  • 1. The effectiveness of chemotherapy in localized malignant fibrous histiocytoma (MFH) of bone: the Rizzoli Institute experience with 66 patients treated with surgery alone or surgery + adjuvant or neoadjuvant chemotherapy.
    Bacci G; Avella M; Picci P; Capanna R; Fontana M; Dallari D; Campanacci M
    Chemioterapia; 1988 Dec; 7(6):406-13. PubMed ID: 2851393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neoadjuvant chemotherapy in malignant fibrous histiocytoma of the limbs: 10 years of experience (1983-1992) at the Rizzoli Orthopedic Institute].
    Bacci G; Ferrari S; Picci P; Forni C; Donati D; Manfrini M; Baldini N; Iantorno D; Campanacci M
    Minerva Med; 1996 Apr; 87(4):135-46. PubMed ID: 8700337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy for high grade malignant fibrous histiocytoma of bone.
    Bacci G; Picci P; Mercuri M; Bertoni F; Ferrari S
    Clin Orthop Relat Res; 1998 Jan; (346):178-89. PubMed ID: 9577426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy for malignant fibrous histiocytoma of bone and for osteosarcoma of the limbs: a comparison between the results obtained for 21 and 144 patients, respectively, treated during the same period with the same chemotherapy protocol.
    Bacci G; Mercuri M; Ruggieri P; Ferraro A; Bertoni F; Tella G; Ferrari S; Iantorno D
    Chir Organi Mov; 1996; 81(2):139-53. PubMed ID: 8968117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999.
    Bacci G; Longhi A; Ferrari S; Mercuri M; Barbieri E; Bertoni F; Bacchini P; Picci P
    Eur J Surg Oncol; 2006 Nov; 32(9):974-9. PubMed ID: 16621429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
    Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60: report of 35 cases and comparison of results with 586 younger patients treated with the same protocols in the same years.
    Bacci G; Balladelli A; Forni C; Ferrari S; Longhi A; Bacchini P; Alberghini M; Fabbri N; Benassi M; Briccoli A; Picci P
    Cancer; 2007 Feb; 109(4):780-6. PubMed ID: 17219445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)].
    Bacci G; Ferrari S; Rosito P; Barbieri E; Mercuri M; Brach del Prever A; Iantorno D; Forni C; Campanacci M
    Minerva Pediatr; 1995 Nov; 47(11):457-69. PubMed ID: 8684341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of surgery in local treatment of Ewing's sarcoma of the extremities in patients undergoing adjuvant and neoadjuvant chemotherapy.
    Bacci G; Ferrari S; Longhi A; Donati D; Barbieri E; Forni C; Bertoni F; Manfrini M; Giacomini S; Bacchini P
    Oncol Rep; 2004 Jan; 11(1):111-20. PubMed ID: 14654912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy.
    Bacci G; Briccoli A; Longhi A; Ferrari S; Mercuri M; Faggioli F; Versari M; Picci P
    Acta Oncol; 2005; 44(7):748-55. PubMed ID: 16227167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy.
    Bacci G; Longhi A; Fagioli F; Briccoli A; Versari M; Picci P
    Eur J Cancer; 2005 Dec; 41(18):2836-45. PubMed ID: 16298125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy in the treatment of osteosarcoma of the extremities: preliminary results in 131 cases treated preoperatively with methotrexate and cisdiamminoplatinum.
    Bacci G; Avella M; Capanna R; Boriani S; Dallari D; Galletti S; Giunti A; Madon E; Mancini A; Mercuri M
    Ital J Orthop Traumatol; 1988 Mar; 14(1):23-39. PubMed ID: 3235324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
    J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant fibrous histiocytoma and other fibrohistiocytic tumors in pediatric patients: the St. Jude Children's Research Hospital experience.
    Daw NC; Billups CA; Pappo AS; Jenkins JJ; Mahmoud HH; Krasin MJ; Rao BN
    Cancer; 2003 Jun; 97(11):2839-47. PubMed ID: 12767098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of polychemotherapy in the management of malignant bone tumors].
    Reichardt P; Dörken B
    Chirurg; 2002 Dec; 73(12):1170-3. PubMed ID: 12491045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis.
    Le Doussal V; Coindre JM; Leroux A; Hacene K; Terrier P; Bui NB; Bonichon F; Collin F; Mandard AM; Contesso G
    Cancer; 1996 May; 77(9):1823-30. PubMed ID: 8646680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of high-dose methotrexate-based neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone.
    Ham SJ; Hoekstra HJ; van der Graaf WT; Kamps WA; Molenaar WM; Schraffordt Koops H
    J Clin Oncol; 1996 Feb; 14(2):490-6. PubMed ID: 8636762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: the Rizzoli Institute experience.
    Bacci G; Balladelli A; Palmerini E; Alberghini M; Pollastri P; Galletti S; Mercuri M; Picci P
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):908-12. PubMed ID: 19131777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy for osseous malignant fibrous histiocytoma of the extremity: results in 18 cases and comparison with 112 contemporary osteosarcoma patients treated with the same chemotherapy regimen.
    Bacci G; Ferrari S; Bertoni F; Mercuri M; Forni C; Sottili S; Gasbarrini A; Tienghi A; Cesari M; Campanacci M
    J Chemother; 1997 Aug; 9(4):293-9. PubMed ID: 9269611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neoadjuvant chemotherapy in malignant fibrous histiocytoma of the extremities. Preliminary results in 10 cases treated preoperatively with methotrexate and cisplatin].
    Bettelli G; Avella M; Capanna R; Dallari D; Picci P; Campanacci M; Bacci G
    Chir Organi Mov; 1987; 72(2):111-7. PubMed ID: 2824137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.